UNM:NYE-Unum Group (USD)

COMMON STOCK | Insurance - Life |

Last Closing

USD 75.45

Change

+0.47 (+0.63)%

Market Cap

N/A

Volume

0.88M

Analyst Target

USD 21.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-21 )

Largest Industry Peers for Insurance - Life

Symbol Name Price(Change) Market Cap
AFL Aflac Incorporated

-0.10 (-0.09%)

USD 57.31B
MET-PA MetLife Inc Preferred Stock Se..

-0.01 (-0.04%)

USD 48.79B
MET-PE MetLife Inc Preferred Stock Se..

+0.33 (+1.38%)

USD 42.53B
PRU Prudential Financial Inc

+1.26 (+1.06%)

USD 42.36B
PUK Prudential PLC ADR

+0.26 (+1.64%)

USD 20.90B
PRI Primerica Inc

+1.39 (+0.48%)

USD 9.75B
JXN Jackson Financial Inc

+3.11 (+3.36%)

USD 6.25B
FG F&G Annuities & Life Inc.

-0.03 (-0.07%)

USD 4.95B
ANG-PA American National Group Inc.

+0.03 (+0.12%)

N/A
MET-PF MetLife Inc Preferred Stock Se..

+0.49 (+2.37%)

N/A

ETFs Containing UNM

FLI:CA CI U.S. & Canada Lifeco C.. 12.46 % 0.92 %

+0.16 (+0.67%)

CAD 0.09B
FTDS First Trust Dividend Stre.. 2.29 % 0.00 %

+0.36 (+0.67%)

USD 0.03B
RAYD Rayliant Quantitative Dev.. 2.18 % 0.00 %

+0.43 (+0.67%)

USD 0.06B
XMVM Invesco S&P MidCap Value .. 1.81 % 0.39 %

+0.94 (+0.67%)

USD 0.26B
IVOV Vanguard S&P Mid-Cap 400 .. 0.86 % 0.20 %

+1.29 (+0.67%)

USD 0.95B
2B77:XETRA iShares Ageing Population.. 0.79 % 0.00 %

+0.04 (+0.67%)

USD 0.50B
UIMS:XETRA UBS (Irl) ETF plc - UBS (.. 0.71 % 0.00 %

+0.03 (+0.67%)

USD 0.07B
WSCSRI:SW UBS (Irl) ETF plc - UBS (.. 0.71 % 0.00 %

+0.12 (+0.67%)

USD 0.47B
WSCR:LSE UBS (Irl) ETF plc - MSCI .. 0.69 % 0.00 %

+5.85 (+0.67%)

USD 0.01B
PAPI Morgan Stanley ETF Trust 0.62 % 0.00 %

+0.18 (+0.67%)

USD 0.12B
JMEE JPMorgan Market Expansion.. 0.54 % 0.00 %

+1.00 (+0.67%)

USD 1.61B
ZEUS:CA 0.00 % 0.73 %

N/A

N/A
AFMC First Trust Active Factor.. 0.00 % 0.00 %

+0.58 (+0.67%)

USD 0.03B
DFAT Dimensional U.S. Targeted.. 0.00 % 0.00 %

+0.73 (+0.67%)

USD 10.74B
2B77:F iShares Ageing Population.. 0.00 % 0.00 %

+0.01 (+0.67%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Insurance - Life) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.31% 58% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.31% 58% F 61% D-
Trailing 12 Months  
Capital Gain 61.60% 89% A- 94% A
Dividend Return 3.36% 50% F 49% F
Total Return 64.96% 89% A- 94% A
Trailing 5 Years  
Capital Gain 163.17% 93% A 93% A
Dividend Return 22.78% 67% D+ 71% C-
Total Return 185.94% 93% A 93% A
Average Annual (5 Year Horizon)  
Capital Gain 34.16% 89% A- 89% A-
Dividend Return 38.37% 89% A- 90% A-
Total Return 4.21% 75% C 76% C+
Risk Return Profile  
Volatility (Standard Deviation) 28.89% 44% F 37% F
Risk Adjusted Return 132.79% 100% F 99% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.